In recent years, tirzepatide has gained enormous attention among doctors and patients. This medication, used in the treatment of type 2 diabetes, obesity, and overweight with complications, helps lower blood glucose levels and supports weight reduction. In this article, LuMedic presents the most important information about tirzepatide.
What Is Tirzepatide and How Does It Work?
Mechanism of action
Tirzepatide (Mounjaro) mimics the gut hormones that are released in response to food intake. It activates GLP-1 and GIP receptors, which:
- increase insulin secretion,
- lower glucagon (depending on glucose concentration),
- slow gastric emptying,
- reduce hunger,
contribute to weight loss.
Indications for Use
Tirzepatide is prescribed as an adjunct to diet and exercise in adults with:
- type 2 diabetes,
- obesity (BMI ≥30 kg/m²),
- overweight (BMI ≥27 kg/m²) with weight-related comorbidities.
Tirzepatide – Side Effects and What to Know
Most common adverse effects
The most frequently reported side effects are gastrointestinal:
- nausea,
- diarrhea,
- constipation,
- vomiting.
These are usually mild to moderate, occur more often during dose escalation, and diminish over time.
Use in pregnancy and breastfeeding
Tirzepatide (Mounjaro) should not be used during pregnancy or breastfeeding. There is insufficient safety data in pregnant women.
Missed dose – what to do?
- If you miss a dose, administer it as soon as possible within 4 days after the scheduled time.
If more than 4 days have passed, skip the missed dose and take the next dose on the usual scheduled day.
Dosage and Administration
Tirzepatide is administered subcutaneously into the:
- abdominal wall,
- thigh,
- upper arm.
It may be injected regardless of meals or time of day, with injection sites rotated.
Dosing schedule:
- Start: 2.5 mg once weekly.
- After 4 weeks: increase to 5 mg once weekly.
- Then: dose may be increased in 2.5 mg increments after at least 4 weeks at the current dose if needed.
- Maintenance doses: 5 mg, 10 mg, or 15 mg once weekly.
Maximum dose: 15 mg once weekly.
Tirzepatide – Price and Therapy Costs
What influences the price?
- Dosage (lower: 2.5–5 mg; higher: 10–15 mg).
- Availability and pharmacy ordering requirements.
Approximate prices:
- Poland: PLN 1200/month (2.5 mg weekly) to PLN 2000/month (15 mg weekly).
- Italy: ~€400 per 10 mg pen (4 doses/month).
- United States:
- Zepbound vials: ~$400–500 for 4 weeks.
Pen form: ~$1300 for 4 weeks.
Storage Instructions
- Store in refrigerator (2–8°C). Do not freeze.
- Keep in original packaging to protect from light.
May be stored outside the refrigerator for up to 21 days at temperatures ≤30°C.
Tirzepatide Without Prescription – Is It Possible?
Legal availability in pharmacies
In Poland, tirzepatide is available by prescription only at brick-and-mortar pharmacies. It is not reimbursed.
Risks of online purchase without prescription
Buying tirzepatide without a prescription (e.g., online) carries serious risks:
- counterfeit or improperly stored drugs,
- lack of quality control and dosing reliability,
- no medical supervision (risk of severe side effects).
Self-ordering tirzepatide without a prescription is strongly discouraged. Only medication dispensed by a pharmacy with a valid prescription ensures safety.
Alternatives to Tirzepatide
Other prescription weight-loss drugs:
- GLP-1 analogues: liraglutide (Saxenda), semaglutide (Wegovy),
- phentermine-topiramate (Qsymia),
- naltrexone-bupropion (Mysimba).
Choice depends on indications, patient profile, and drug availability.
Over-the-counter supplements:
Only dietary supplements, herbal remedies, and digestion aids are available without prescription. They are not comparable to tirzepatide in terms of effectiveness and lack randomized clinical trial evidence. They may support diet and activity but do not replace pharmacological therapy.
Summary – Tirzepatide as Support, But With Caution
Tirzepatide is indicated for the treatment of type 2 diabetes and obesity/overweight with complications. It acts by mimicking GLP-1 and GIP gut hormones, improving glycemic control and supporting weight loss. Adverse effects are mostly gastrointestinal and usually mild.
Tirzepatide therapy should be strictly supervised by a physician. In Poland, the medication is available only by prescription, with monthly costs ranging from PLN 1200 to 2000. Buying it online without a prescription poses serious health risks and is not recommended. OTC alternatives may support lifestyle changes but cannot replace properly prescribed and monitored tirzepatide therapy.
References:
https://ec.europa.eu/health/documents/community-register/2023/20231211161235/anx_161235_pl.pdf